Synlett 2008(17): 2681-2683  
DOI: 10.1055/s-0028-1083526
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

First Total Synthesis of (±)-Powelline

Hany F. Anwar, Trond Vidar Hansen*
School of Pharmacy, Department of Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068, Blindern, 0316 Oslo, Norway
Fax: +47(22)855947; e-Mail: t.v.hansen@farmasi.uio.no;
Further Information

Publication History

Received 23 June 2008
Publication Date:
01 October 2008 (online)

Abstract

The first total synthesis of (±)-powelline is reported in 10% overall yield over eight steps using an intramolecular oxidative phenolic coupling reaction as the key reaction.

    References and Notes

  • 1a Martin SF. The Amaryllidaceae Alkaloids, In Alkaloids   Vol. 30:  Brossi A. Academic; New York NY: 1987.  p.251 
  • 1b Hoshin O. The Amaryllidaceae Alkaloids, In Alkaloids   Vol. 51:  Cordell GA. Academic; New York NY: 1998.  p.323 
  • 1c Jin Z. Nat. Prod. Rep.  2007,  24:  886 
  • 1d Jin Z. Nat. Prod. Rep.  2005,  22:  111 
  • 1e Jin Z. Nat. Prod. Rep.  2003,  20:  606 
  • 1f Jin Z. Li Z. Huang R. Nat. Prod. Rep.  2002,  19:  454 
  • 1g Nguyen TNT. Titorenkova TV. Bankova VS. Handjieva NV. Popov SS. Fitoterapia  2002,  73:  183 
  • 1h Unver N. Phytochem. Rev.  2007,  6:  125 
  • 1i Lewis JR. Nat. Prod. Rep.  1990,  7:  549 
  • 2 Elgorashi EE. Stafford GI. Van Staden J. Planta Med.  2004,  70:  260 
  • 3a Likhitwitayawuid K. Angerhofer CK. Chai H. Pezzuto JM. Cordell GA. Ruangrungsi N. J. Nat. Prod.  1993,  56:  1331 
  • 3b Lin LZ. Hu SF. Chai HB. Pengsuparp T. Pezzuto JM. Cordell GA. Ruangrungsi N. Phytochemistry  1995,  40:  1295 
  • 3c McNulty J. Nair JJ. Codina C. Bastida J. Pandey S. Gerasimoff J. Griffin C. Phytochemistry  2007,  68:  1068 
  • 4a Hoet S. Opperdoes F. Brun R. Quetin-Leclercq J. Nat. Prod. Rep.  2004,  21:  353 
  • 4b Sener B. Orhan I. Satayavivad J. Phytother. Res.  2003,  17:  1220 
  • 4c Schwikkard S. Van Heerden FR. Nat. Prod. Rep.  2002,  19:  675 
  • 4d Citoglu G. Tanker M. Gumusel B. Phytother. Res.  1998,  12:  205 
  • 4e Weniger B. Italiano L. Beck JP. Bastida J. Bergonon S. Codina C. Lobstein A. Anton R. Planta Med.  1995,  61:  77 
  • 5a Hudlicky T. J. Heterocycl. Chem.  2000,  37:  535 
  • 5b Rinner U. Hudlicky T. Synlett  2005,  365 
  • 5c Agarwal S. Caemmerer S. Filali S. Froehner W. Knoell J. Krahl MP. Reddy KR. Knolker H.-J. Curr. Org. Chem.  2005,  9:  1601 
  • 5d Chapleur Y. Chretien F. Ahmed SI. Khaldi M. Curr. Org. Synth.  2006,  3:  341 
  • 5e Hudlicky T. Arkivoc  2006,  (vii):  276 
  • 5f Ghosal S. Saini KS. Razdan S. Phytochemistry  1985,  24:  2141 
  • For syntheses of racemic crinine and epicrinine, see:
  • 6a Tam NT. Cho C.-G. Org. Lett.  2008,  10:  601 
  • 6b Bru C. Guillou C. Tetrahedron  2006,  62:  9043 
  • 6c Kodama S. Takita H. Kajimoto T. Nishide K. Node M. Tetrahedron  2004,  60:  4901 
  • 6d Pearson WH. Lovering FE. J. Org. Chem.  1998,  63:  3607 
  • 6e Pearson WH. Lovering FE. Tetrahedron Lett.  1994,  35:  9173 
  • 6f Martin SF. Campbell CL. J. Org. Chem.  1988,  53:  3184 
  • 6g Martin SF. Campbell CL. Tetrahedron Lett.  1987,  28:  503 
  • 6h Overman LE. Mendelson LT. J. Am. Chem. Soc.  1981,  103:  5579 
  • 6i Whitlock HW. Smith GL. J. Am. Chem. Soc.  1967,  89:  3600 
  • 6j Muxfeldt H. Schneider RS. Mooberry JB. J. Am. Chem. Soc.  1966,  88:  3670 
  • 6k For synthesis of (-)-crinine, see: Overman LE. Sugai S. Helv. Chim. Acta  1985,  68:  745 
  • 7a Fennell CW. Elgorashi EE. van Staden J. J. Nat. Prod.  2003,  66:  1524 
  • 7b Abd El Hafiz MA. Ramadan MA. Jung ML. Beck JP. Anton R. Planta Med.  1991,  57:  437 
  • 7c Ramires A. Cabezas F. Bastida J. Viladomat F. Codina C. Rev. Latinoam. de Quim.  2001,  29:  26 
  • 8a Elgorashi EE. Stafford GI. Jäger AK. van Staden J. Planta Med.  2006,  72:  470 
  • 8b Risa J. Risa A. Adsersen A. Gauguin B. Stafford GI. van Staden J. Jäger AK. J. Ethnopharmacol.  2004,  93:  177 
  • 9 Baker W. Jukes EHT. Subrahmanyam CA. J. Chem. Soc.  1934,  1681 
  • 10a Hofsløkken NU. Skattebøl L. Acta Chem. Scand.  1999,  53:  258 
  • 10b Hansen TV. Skattebøl L. Org. Synth.  2005,  82:  64 
  • 11a Anwar HF. Hansen TV. Tetrahedron Lett.  2008,  49:  4443 
  • 11b Anwar HF. Skattebøl L. Hansen TV. Tetrahedron  2007,  63:  9997 
  • 11c Hansen TV. Skattebøl L. Tetrahedron Lett.  2005,  46:  3829 
  • 11d Hansen TV. Skattebøl L. Tetrahedron Lett.  2005,  46:  3357 
  • 11e Anwar HF. Skattebøl L. Skramstad J. Hansen TV. Tetrahedron Lett.  2005,  46:  5285 
  • 12 Luche JL. Rodriguez-Hahn L. Crabbe P. J. Chem. Soc., Chem. Commun.  1978,  601 
  • 14a Mitsunobu O. Yamada M. Mukaiyama T. Bull. Chem. Soc. Jpn.  1967,  40:  935 
  • 14b Mitsunobu O. Yamada M. Bull. Chem. Soc. Jpn.  1967,  40:  2380 
  • 14c Mitsunobu O. Synthesis  1981,  1 
  • 14d Lawrence S. PharmaChem.  2002,  1:  12 
  • 15a Frahm AW. Ali Ahmed A. Ramadan MA. Magn. Reson. Chem.  1985,  23:  804 
  • 15b Kobayashi S. Tokumoto T. Kihara M. Imakura Y. Shingu T. Taira Z. Chem. Pharm. Bull.  1984,  32:  3015 
  • 16 Wildman WC. Chem. Ind. (London)  1956,  1090 
13

Analytical and Spectroscopic Data of Selected Compounds:
Compound 9: white solid; mp 147-149 ˚C. ¹H NMR (300 MHz, DMSO-d 6): δ = 9.20 (br s, 1 H), 6.94 (d, J = 8.4 Hz, 2 H), 6.71 (d, J = 7.9 Hz, 1 H), 6.63 (d, J = 8.4 Hz, 2 H), 6.52 (d, J = 7.9 Hz, 1 H), 5.94 (s, 2 H), 3.82 (s, 3 H), 3.56 (s, 2 H), 3.41 (br s, 1 H), 2.54-2.63 (m, 4 H). ¹³C NMR (75 MHz, DMSO-d 6): δ = 155.44, 147.90, 141.40, 136.26, 130.49, 129.45, 125.94, 122.06, 115.07, 102.30, 100.89, 59.47, 50.51, 47.68, 35.00. HRMS: m/z [M+] calcd for C17H19NO4: 301.1314; found: 301.1302.
Compound 10: colorless oil. ¹H NMR (300 MHz, CDCl3):
δ = 6.98-7.02 (m, 2 H), 6.74-6.80 (m, 2 H), 6.51-6.53 (m, 2 H), 5.94 (d, J = 3.0 Hz, 2 H), 5.20 (br s, 1 H), 4.63 (s, 1 H), 4.42 (s, 1 H), 4.01 (d, J = 7.8 Hz, 3 H), 3.41-3.50 (m, 2 H),
2.70-2.84 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 155.04, 154.84, 150.02, 149.85, 142.43, 142.12, 136.59, 136.53, 130.63, 130.35, 130.24, 129.91, 123.83, 122.10, 120.70, 119.93, 116.01, 115.83, 103.24, 102.95, 101.62, 101.52, 60.04, 59.90, 48.63, 44.59, 34.75, 32.38. HRMS: m/z [M+] calcd for C19H18F3NO5: 397.1137; found: 397.1125.
Compound 11: yellow crystals; mp 142-144 ˚C. ¹H NMR (300 MHz, CDCl3): δ = 6.94 (m, 1 H), 6.81 (m, 1 H),
6.21-6.27 (m, 3 H), 5.90 (s, 2 H), 4.91 (d, J = 5.7 Hz, 2 H), 4.03 (d, J = 8.0 Hz, 3 H), 3.88 (m, 2 H), 2.36 (t, J = 6.3 Hz, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 185.65, 185.43, 157.95 (m), 153.18, 152.95, 149.36, 149.32, 141.94, 141.05, 137.25, 136.06, 130.97, 130.46, 127.49, 127.48, 122.57, 122.16, 118.74, 118.55, 114.92, 114.74, 104.94, 104.39, 102.08, 101.73, 60.21, 49.16, 48.71, 45.65 (d, J = 3.4 Hz), 44.64, 40.47 (d, J = 3.4 Hz), 40.00, 35.47, 33.90. HRMS:
m/z [M+] calcd for C19H16F3NO5: 395.0981; found: 395.0968. Compound 12: white crystals; mp 175-177 ˚C (lit.¹6 mp 177-178 ˚C). ¹H NMR (300 MHz, DMSO-d 6): δ = 7.86 (d, J = 10.3 Hz, 1 H), 6.93 (s, 1 H), 5.90-5.94 (m, 3 H), 4.03 (d, J = 17.3 Hz, 1 H), 3.88 (s, 3 H), 3.64 (d, J = 17.3 Hz, 1 H), 3.46 (m, 1 H), 3.36 (m, 1 H), 2.81 (m, 1 H), 2.48 (m, 1 H), 2.30 (m, 1 H), 2.13 (m, 2 H). ¹³C NMR (75 MHz, DMSO-d 6): δ = 197.93, 150.97, 147.91, 140.49, 137.45, 133.57, 127.89, 117.62, 100.71, 97.34, 67.96, 59.00, 57.41, 53.69, 44.48, 44.48, 39.78. HRMS: m/z [M+] calcd for C17H17NO4: 299.1158; found: 299.1151.
Compound 13: white crystals; mp 102-104 ˚C. ¹H NMR (600 MHz, DMSO-d 6): δ = 6.67 (s, 1 H), 6.38 (dd, J = 10.2, 2.1 Hz, 1 H), 5.88 (ABq, 2 H), 5.61 (d, J = 10.2 Hz, 1 H), 4.90 (br s, 1 H), 4.16 (m, 1 H), 4.06 (d, J = 17.3 Hz, 1 H), 3.86 (s, 3 H), 3.62 (d, J = 17.3 Hz, 1 H), 3.22 (m, 1 H), 3.02 (dd, J = 13.2, 3.4 Hz, 1 H), 2.77 (m, 1 H), 1.98 (m, 1 H), 1.92 (m, 1 H), 1.82 (m, 1 H), 1.42 (m, 1 H). ¹³C NMR (75 MHz, DMSO-d 6): δ = 147.53, 140.30, 139.77, 133.12, 132.69, 127.65, 117.03, 100.42, 97.14, 65.88, 65.82, 58.86, 57.74, 52.70, 44.73, 43.91, 34.37. HRMS: m/z [M+] calcd for C17H19NO4: 301.1314; found: 301.1316. The NOESY experiment was recorded on a Bruker Avance DPX-600 MHz spectrometer at 300.3 K with F2 acquisition parameters D1 = 2.00 s and D8 = 0.89 s using DMSO-d 6 as solvent.
Compound 2: white crystals; mp 165-167 ˚C (dec.). ¹H NMR (300 MHz, CDCl3): δ = 6.56 (s, 1 H), 6.52 (d, J = 10.0 Hz, 1 H), 5.95 (dd, J = 10.0, 5.1 Hz, 1 H), 5.85 (ABq, 2 H), 4.35 (m, 1 H), 4.28 (d, J = 17.3 Hz, 1 H), 3.97 (s, 3 H), 3.85 (d, J = 17.3 Hz, 1 H), 3.43 (m, 2 H), 2.90 (m, 1 H), 2.15 (m, 2 H), 1.94 (m, 1 H), 1.76 (m, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 148.23, 140.93, 138.83, 133.45, 131.68, 127.64, 116.42, 100.62, 96.79, 63.72, 62.62, 59.14, 58.40, 53.56, 44.22, 43.68, 32.39. HRMS: m/z [M+] calcd for C17H19NO4: 301.1314; found: 301.1307.